180 related articles for article (PubMed ID: 8496902)
1. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
Jacobson KA; Gallo-Rodriguez C; Melman N; Fischer B; Maillard M; van Bergen A; van Galen PJ; Karton Y
J Med Chem; 1993 May; 36(10):1333-42. PubMed ID: 8496902
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
Kim HO; Ji XD; Melman N; Olah ME; Stiles GL; Jacobson KA
J Med Chem; 1994 Sep; 37(20):3373-82. PubMed ID: 7932565
[TBL] [Abstract][Full Text] [Related]
3. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
Jacobson KA; Kiriasis L; Barone S; Bradbury BJ; Kammula U; Campagne JM; Secunda S; Daly JW; Neumeyer JL; Pfleiderer W
J Med Chem; 1989 Aug; 32(8):1873-9. PubMed ID: 2754711
[TBL] [Abstract][Full Text] [Related]
4. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
5. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
Schwabe U; Ukena D; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
[TBL] [Abstract][Full Text] [Related]
6. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA
Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116
[TBL] [Abstract][Full Text] [Related]
7. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
Martinson EA; Johnson RA; Wells JN
Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
[TBL] [Abstract][Full Text] [Related]
8. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
Shimada J; Suzuki F; Nonaka H; Ishii A
J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
[TBL] [Abstract][Full Text] [Related]
9. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
Daly JW; Padgett W; Shamim MT; Butts-Lamb P; Waters J
J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
[TBL] [Abstract][Full Text] [Related]
10. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
Shamim MT; Ukena D; Padgett WL; Daly JW
J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
[TBL] [Abstract][Full Text] [Related]
11. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
[TBL] [Abstract][Full Text] [Related]
12. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
13. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
Linden J; Patel A; Earl CQ; Craig RH; Daluge SM
J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
[TBL] [Abstract][Full Text] [Related]
15. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
[TBL] [Abstract][Full Text] [Related]
16. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
[TBL] [Abstract][Full Text] [Related]
17. Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents.
Daly JW; Padgett WL; Shamim MT
J Med Chem; 1986 Aug; 29(8):1520-4. PubMed ID: 3016270
[TBL] [Abstract][Full Text] [Related]
18. Adenosine receptors: development of selective agonists and antagonists.
Daly JW; Jacobson KA; Ukena D
Prog Clin Biol Res; 1987; 230():41-63. PubMed ID: 3588607
[TBL] [Abstract][Full Text] [Related]
19. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
[TBL] [Abstract][Full Text] [Related]
20. Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptors.
Jacobson KA; Guay-Broder C; van Galen PJ; Gallo-Rodriguez C; Melman N; Jacobson MA; Eidelman O; Pollard HB
Biochemistry; 1995 Jul; 34(28):9088-94. PubMed ID: 7542477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
